What is the recommended weight‑based loading dose and continuous infusion rate of midazolam for a child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Midazolam Continuous Infusion Dosing for Pediatric Patients

For pediatric continuous midazolam infusion, use a loading dose of 0.05-0.2 mg/kg IV over 2-3 minutes (in intubated patients only), followed by a continuous infusion starting at 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min), titrating by 25% increments as needed. 1

Loading Dose

  • 0.05-0.2 mg/kg IV administered over at least 2-3 minutes
  • Only for intubated patients - do not use rapid IV bolus 1
  • For non-intubated patients or procedural sedation, loading doses are not recommended in the continuous infusion context

Continuous Infusion Rate

Starting rate: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 1

Titration approach:

  • Increase or decrease by 25% of the current infusion rate as needed 1
  • Supplemental IV boluses can be given to rapidly increase effect
  • Maximum rate: Up to 5 mg/kg/min (0.3 mg/kg/hr) for refractory status epilepticus 2

Age-Specific Considerations

Neonates (Term and Preterm)

  • <32 weeks gestation: Start at 0.03 mg/kg/hr (0.5 mcg/kg/min) 1
  • >32 weeks gestation: Start at 0.06 mg/kg/hr (1 mcg/kg/min) 1
  • Do NOT use loading doses in neonates - instead, run the infusion more rapidly for the first several hours 1
  • Extreme caution required due to increased apnea risk, especially in non-intubated patients

Infants and Children (Non-neonatal)

  • Standard dosing applies: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 1
  • Loading dose of 0.05-0.2 mg/kg can be used if intubated 1

Context-Specific Dosing

For Refractory Status Epilepticus

The evidence strongly supports a specific escalation protocol 2:

  1. Loading dose: 0.15-0.2 mg/kg IV
  2. Initial infusion: 1 mcg/kg/min (0.06 mg/kg/hr)
  3. Titration: Increase by 1 mcg/kg/min increments every 15 minutes until seizures stop
  4. Maximum: 5 mcg/kg/min (0.3 mg/kg/hr)

Recent research suggests that early use of midazolam at 2-5 mcg/kg/min (0.12-0.3 mg/kg/hr) may be more effective than starting at the traditional 1 mcg/kg/min, with seizure cessation occurring within 10-70 minutes in 92% of patients 3, 4. Low-dose midazolam (<0.2 mg/kg/hr) administered early (after single benzodiazepine or one ASM) showed 59% effectiveness, dropping to 37% when used after multiple ASMs 4.

For Sedation in Critical Care

  • Standard starting rate: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 1
  • Assisted ventilation recommended when combined with opioids or other CNS depressants 1

Critical Safety Considerations

Respiratory monitoring is mandatory:

  • Prepare for respiratory support regardless of route 2
  • Monitor oxygen saturation continuously 2
  • Increased apnea risk when combined with opioids or other sedatives 1

Hemodynamic monitoring:

  • Watch for hypotension, especially in critically ill patients receiving opioids 1
  • In hemodynamically compromised patients, titrate loading dose in small increments 1
  • Monitor blood pressure and heart rate continuously

Drug accumulation risk:

  • Reassess infusion rate frequently, especially after first 24 hours 1
  • Drug elimination delayed with erythromycin/P450-3A4 inhibitors, liver dysfunction, low cardiac output, and in neonates 1
  • Administer lowest effective dose to reduce accumulation potential 1

Common Pitfalls to Avoid

  1. Using loading doses in non-intubated patients - this significantly increases respiratory depression risk
  2. Inadequate titration time - midazolam takes 3-5 minutes to reach peak effect; wait before redosing 2
  3. Starting too low in refractory seizures - evidence suggests 2-5 mcg/kg/min may be more effective than 1 mcg/kg/min 3, 4
  4. Forgetting to reduce dose with concomitant sedatives - particularly important with opioids 1
  5. Inadequate monitoring after 24 hours - drug accumulation becomes significant, requiring dose reduction 1

Conversion from Continuous Infusion

When weaning midazolam after >7 days of continuous use 5:

  1. Calculate 24-hour midazolam dose from hourly infusion rate
  2. Divide by 12 to determine daily lorazepam dose (accounting for potency and half-life differences)
  3. Divide lorazepam dose by 4 and give every 6 hours orally
  4. Wean lorazepam by 10-20% per day, gradually increasing dosing intervals

References

5
Guideline

neonatal drug withdrawal.

Pediatrics, 2012

Related Questions

What is the appropriate loading dose and infusion rate for a midazolam intravenous drip in a patient with refractory seizures, and what monitoring is required?
How should a midazolam drip be prepared and dosed, including the loading dose, dilution concentration, and infusion rate?
Can midazolam be administered to a conscious patient?
Can midazolam be mixed with D5W (5% dextrose in water) for intravenous administration?
What is the elimination half-life of Versed (midazolam) in healthy adults?
What are the recommended acute and preventive treatment options and dosages for a severe migraine attack in an adult patient?
Should I start leflunomide in place of tofacitinib for an adult rheumatoid arthritis patient who is currently tolerating tofacitinib with controlled disease activity and no active infection?
Should serum tryptase be measured in a patient with anaphylactic shock after a wasp sting?
Could my left‑arm pain radiating from the shoulder, intermittent central chest discomfort, left‑neck and ear pain, and highly variable heart rate be a panic attack or a cardiac event such as myocardial ischemia?
If I receive medication intended for a suicidal attempt from a psychiatric patient whose caregiver voluntarily gave it to me, what should I do?
In a 41-year-old woman with normal weight, no comorbidities, and a lipid panel showing total cholesterol 219 mg/dL, triglycerides 89 mg/dL, HDL 70 mg/dL, and LDL 137 mg/dL, what is the recommended management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.